Chirotech Technology

Chirotech Technology, commonly known as Chirotech, is a premier technology-driven organization specializing in chiral chemistry and biocatalysis for the pharmaceutical industry. Based in Cambridge, UK, the company provides advanced solutions for the synthesis of single-enantiomer drug intermediates and active pharmaceutical ingredients (APIs). Originally founded as a spin-out from British academia, Chirotech established itself as a leader in asymmetric catalysis before being acquired by Dr. Reddy's Laboratories in 2008. Today, it operates as a center of excellence within Dr. Reddy's Custom Pharma Services, focusing on developing sustainable, cost-effective, and "green" manufacturing processes. Its expertise is utilized by global pharmaceutical companies to streamline the development of complex small molecule therapeutics.